tiprankstipranks

Karen Dawes Insider Profile

25 Followers
Karen Dawes, Director at Repligen, holds 92.82K shares in Repligen (Ticker: RGEN), holds 1.70K shares in Barinthus Biotherapeutics (Ticker: BRNS), holds 84.59K shares in Assertio Therapeutics (Ticker: ASRT).
tipranks
Karen Dawes

Karen Dawes
Repligen (RGEN)
Director

Ranked #82,014 out of 109,030 Corporate Insiders

Profitable Transactions

57%
8 out of 14 Profitable Transactions

Average Return

-9.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15M
100.00%
A breakdown of Karen Dawes's holdings

Insider Roles

Repligen
(RGEN)
Director
Roles that Karen Dawes holds in companies

Most Profitable Insider Trade

Stock:
Assertio Therapeutics
(ASRT)
Rating:Informative Sell
Date:Dec 04, 2018 - Dec 04, 2019
Return:+84.60%
The most profitable trade made by Karen Dawes

Karen Dawes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Repligen
May 18, 2026
Director
Uninformative Buy
$15.33M
BRNS
Barinthus Biotherapeutics
May 06, 2021
Informative Buy
28.90K
$1.26K
ASRT
Assertio Therapeutics
May 11, 2020
Uninformative Sell
12.51K
$1.99M
PDLI
PDL BioPharma
$5.56K
List of latest transactions for each holding click on a transaction to see Karen Dawes's performance on stock

Karen Dawes insider profile FAQ

What is the percentage of profitable transactions made by Karen Dawes?
The percentage of profitable transactions made by Karen Dawes is 57%.
    What is the average return per transaction made by Karen Dawes?
    The average return per transaction made by Karen Dawes is -9.50%.
      What stocks does Karen Dawes hold?
      Karen Dawes holds: RGEN, BRNS, ASRT, PDLI stocks.
        What was Karen Dawes’s latest transaction?
        Karen Dawes latest transaction was an Uninformative Buy of ―.
          What was Karen Dawes's most profitable transaction?
          Karen Dawes’s most profitable transaction was an Informative Sell of ASRT stock on December 4, 2018. The return on the trade was 84.60%.
            What is Karen Dawes's role in Repligen?
            Karen Dawes's role in Repligen is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.